Enhancer of zeste homolog 2 (EZH2), an epigenetic regulator frequently overexpressed in cancer, plays a crucial role in various processes including cancer initiation and progression, invasion and migration, drug resistance, and anti-tumor immunity, thus serving as a significant biomarker in cancer therapy.3 This evidence concerns the gene EZH2 and cancer.